BioSpace News Archive

Press Releases

NLS Pharmaceutics and Kadimastem Announces Up to $3 Million Equity Financing and $25 Million Equity Facility Agreement

April 1, 2025
·
10 min read
Press Releases

The Impact of the VenoValve(R) on Patients with Primary and Secondary Chronic Venous Insufficiency (CVI) to be Presented at the Society for Clinical Vascular Surgery 52nd Annual Symposium

April 1, 2025
·
4 min read
Press Releases

Mitsubishi Tanabe Pharma America to Share Latest Data on Investigational ND0612 at the 2025 International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD)

April 1, 2025
·
4 min read
Press Releases

New Late-Breaking Data Reinforce Benefits of Abbott’s TriClip™ for People With Leaky Tricuspid Heart Valve

April 1, 2025
·
4 min read
Press Releases

Avidity Biosciences Completes Enrollment in Biomarker Cohort in Phase 1/2 FORTITUDE™ Trial for Delpacibart Braxlosiran (del-brax) in People Living with Facioscapulohumeral Muscular Dystrophy

April 1, 2025
·
10 min read
Press Releases

Cycle Vita™ expands patient support in Multiple Sclerosis (MS) to include BAFIERTAM® (monomethyl fumarate) delayed-release capsules

April 1, 2025
·
11 min read
Press Releases

SAB BIO Reports Full Year 2024 Operating and Financial Results

April 1, 2025
·
6 min read
Press Releases

Maze Therapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Highlights

April 1, 2025
·
10 min read
Press Releases

IMFINZI® (durvalumab) approved in the US as first and only perioperative immunotherapy for patients with muscle-invasive bladder cancer

April 1, 2025
·
19 min read
Press Releases

Palatin Announces MC4R Agonist Bremelanotide Co-Administered with GLP-1/GIP Tirzepatide Meets Primary Endpoint in Phase 2 Obesity Study

April 1, 2025
·
9 min read